Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Camidge is the Director of Thoracic Oncology at the University of Colorado.

Lung Cancer Video Library - ALK Rearrangements: What Are They, and Who Has Them?
Sat, 04/09/2016 - 06:00
Author
David Ross Camidge, MD, PhD, GRACE Faculty
Image
 

Dr. Ross Camidge, University of Colorado, describes ALK rearrangements and the characteristics of patients who most often have them.

 

Transcript

ALK stands for anaplastic lymphoma kinase. This is a gene which is involved in the development when we’re a little tiny embryo, and then it gets turned off when we become an adult. As an embryo, it’s involved in the development of the gut and the nervous system and a few other things. It’s silenced in most adult tissues, but it can be turned on again by what’s called a gene rearrangement. What that means is it brings in the front part of another gene which drives the expression of the previously silenced ALK, then it actually functions as something so powerful that it can actually turn a normal cell into a cancer cell.

The absolute frequency is running somewhere between 3% and 7% of lung cancer. The people who tend to have these more often tend to be people with a kind of lung cancer called adenocarcinoma of the lung — that’s what it looks like in the microscope, comes from glandular tissue. It tends to be more common in never smokers, it’s slightly more common in people who are younger than the average age of people who develop lung cancer, maybe a decade or so.

You also need to understand that all of these factors which are associated with it are not exclusive. So you can be older, you can have a history of smoking, you can have non-adenocarcinoma and still have an ALK rearrangement that may respond very well to an ALK inhibitor. So you have to understand the difference between an enrichment factor, and an absolute — "you should never test", or "always test.” For me, I test everybody unless they have a 0% chance, and that’s a very small group that has a 0% chance. Essentially I test everybody with non-small cell lung cancer.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Mandarin LCVL
Video
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit: https://www.youtube.com/playlist?list=PLWsyUmdjLXhGnSxobmz4CBP3pxAj7nDa…;  
Image
Tell your story!  Apply now for the Clinical Trials Experiences through Storytelling Program
Article
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now!     GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview  
Image
Blood Cancer OncTalk
Video
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.

Forum Discussions

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Recent Comments

JOIN THE CONVERSATION
Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
Concerned
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29